SD BioSensor

Update in progress

137310.KS (KSE)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

SD Biosensor, Inc. and its subsidiaries are a global in vitro diagnostics company based in Suwon-si, South Korea, founded in 1999. The company develops and exports a range of products, including STANDARD Q rapid tests; STANDARD F fluorescence immunodiagnostic systems; STANDARD E large-volume enzyme immunoassay tests; STANDARD M field molecular diagnostics; and STANDARD i chemiluminescence analyzers for biomarkers. It also offers blood glucose meters, transport media, incubators, various analyzers, G6PD and LipidoCare devices, and at-home COVID-19 tests.

Company score

Sentiment: 0.51; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.46; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.17; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.17; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.34; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive